| Bioactivity | Ozarelix (D-63153) is a GnRH antagonist. Ozarelix induces cell apoptosis and arrests cell in G2/M phase. Ozarelix can be used in the research of prostate cancer[1]. |
| Invitro | Ozarelix (0-20 ng/mL, 72 h) inhibits PC3 and DU145 cell proliferation[1].Ozarelix (0-20 ng/mL, 72 h) induces apoptosis in PC3 and DU145 cells[1].Ozarelix (20 ng/mL, 72 h) triggers caspase 8-dependent caspase 3 activation[1]. Cell Proliferation Assay[1] Cell Line: |
| Name | Ozarelix |
| CAS | 295350-45-7 |
| Formula | C72H96ClN17O14 |
| Molar Mass | 1459.09 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Ozarelix
CAS: 295350-45-7 F: C72H96ClN17O14 W: 1459.09
Ozarelix (D-63153) is a GnRH antagonist. Ozarelix induces cell apoptosis and arrests cell in G2/M phase. Ozarelix can be
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.